Evidence map›Paper›PMID 36889586›Full record

ArticleThe Journal of biological chemistry2023

NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action.

Timur N Bozin, Igor M Berdyshev, Ksenia N Chukhontseva, Maria A Karaseva, Petr V Konarev, Anna M Varizhuk, Dmitry M Lesovoy, Alexander S Arseniev, Sergey V Kostrov, Eduard V Bocharov and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Timur N BozinInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia; National Research Centre "Kurchatov Institute", Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Igor M BerdyshevInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.
Ksenia N ChukhontsevaInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.
Maria A KarasevaInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.
Petr V KonarevShubnikov Institute of Crystallography of the Federal Scientific Research Centre "Crystallography and Photonics", Russian Academy of Sciences, Moscow, Russia.
Anna M VarizhukMoscow Institute of Physics and Technology, State University, Dolgoprudny, Russia.
Dmitry M LesovoyShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Alexander S ArsenievShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Sergey V KostrovInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.
Eduard V BocharovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia; Moscow Institute of Physics and Technology, State University, Dolgoprudny, Russia.
Ilya V DemidyukInstitute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia. Electronic address: duk@img.ras.ru.
Kurchatov Institute · RUInstitute of Bioorganic Chemistry · RUMoscow Institute of Physics and Technology · RURussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emfourin (M4in) is a protein metalloprotease inhibitor recently discovered in the bacterium Serratia proteamaculans and the prototype of a new family of protein protease inhibitors with an unknown mechanism of action. Protealysin-like proteases (PLPs) of the thermolysin family are natural targets of emfourin-like inhibitors widespread in bacteria and known in archaea. The available data indicate the involvement of PLPs in interbacterial interaction as well as bacterial interaction with other organisms and likely in pathogenesis. Arguably, emfourin-like inhibitors participate in the regulation of bacterial pathogenesis by controlling PLP activity. Here, we determined the 3D structure of M4in using solution NMR spectroscopy. The obtained structure demonstrated no significant similarity to known protein structures. This structure was used to model the M4in-enzyme complex and the complex model was verified by small-angle X-ray scattering. Based on the model analysis, we propose a molecular mechanism for the inhibitor, which was confirmed by site-directed mutagenesis. We show that two spatially close flexible loop regions are critical for the inhibitor-protease interaction. One region includes aspartic acid forming a coordination bond with catalytic Zn

Indexed as

Bacterial ProteinsMetalloproteasesMagnetic Resonance SpectroscopyPeptide HydrolasesThermolysinBacterial ProteinsMetalloproteasesPeptide HydrolasesThermolysinemfouringram-negative bacteriainhibition mechanismmetalloproteasenuclear magnetic resonance (NMR)protealysinprotease inhibitorprotein complexprotein structurethermolysin-like protease

Identifiers

PMID36889586
PMCPMC10124921
OpenAlexW4323304965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.